Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for UnitedHealth Group Incorporated (UNH:NYSE), powered by AI.
UnitedHealth Group Incorporated is currently trading at $407.65. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for UnitedHealth Group Incorporated on Alpha Lenz.
UnitedHealth Group Incorporated's P/E ratio is 30.7.
“UnitedHealth Group Incorporated trades at a P/E of 30.7 (premium valuation) with solid ROE of 12.9%. 3Y revenue CAGR of 11.6% highlights clear growth momentum.”
Ask for details →UnitedHealth Group Incorporated is a diversified healthcare company offering a broad spectrum of health-related services and products. As one of the largest players in the healthcare industry, its primary function is to provide services through its two distinct platforms: UnitedHealthcare, responsible for providing healthcare benefits, and Optum, which provides health services through technology and information. UnitedHealth Group impacts numerous sectors including insurance, healthcare services, and pharmaceuticals, working closely with government agencies, employers, and individual consumers. With its prominent market presence, the company influences healthcare policy and innovation, striving to improve overall community health outcomes and manage healthcare costs effectively. Based in Minnetonka, Minnesota, UnitedHealth’s significant contributions to healthcare make it an essential component of the Dow Jones Industrial Average, reflecting its influence in both the healthcare sector and the broader market.
“UnitedHealth Group Incorporated trades at a P/E of 30.7 (premium valuation) with solid ROE of 12.9%. 3Y revenue CAGR of 11.6% highlights clear growth momentum.”
Ask for details →UnitedHealth Group Incorporated (ticker: UNH) is a company listed on NYSE in the Healthcare sector (Healthcare Plans). It has approximately 400,000 employees. Market cap is $370.1B.
The current price is $407.65 with a P/E ratio of 30.7x and P/B of 3.93x.
ROE is 12.91% and operating margin is 4.24%. Annual revenue is $447.6B.